Wuhan Easy Diagnosis Biomedicine (002932.SZ) announces that as of June 30, 2024, the company has repurchased through a repurchase special securities account...
According to the announcement of Wuhan Easy Diagnosis Biomedicine (002932.SZ) on the Zhijun Finance APP, as of June 30, 2024, the company has repurchased a total of 8.3497 million shares of the company's stock through a repurchase special securities account by means of concentrated bidding, accounting for 3.59% of the company's total share capital. The highest fill price of repurchased shares was 20.98 yuan/share, the lowest fill price was 18.17 yuan/share, and the total transaction amount was 163 million yuan.